Dr. Kenneth Baillie graduated from the University of Edinburgh with a BSc(Hons) in Physiology in 1999 and MBChB in 2002. He completed basic training in medicine in Glasgow, and in anaesthesia in Edinburgh. During this time he led a series of high altitude research projects in Bolivia, and founded a high-altitude research charity. He was appointed as a clinical lecturer on the ECAT (Edinburgh Clinical Academic Track) at the University of Edinburgh in 2008, and completed a Wellcome Trust-funded PhD in statistical genetics in 2012. He was awarded a Wellcome-Beit Prize Intermediate Clinical Fellowship in 2013. After completing clinical training in 2014 he worked as a visiting scientist at the Broad Institute of Harvard and MIT, before returning to the Roslin Institute, University of Edinburgh to establish a research program in translational applications of genomics in critical care medicine. He works as a consultant in the intensive care unit at the Royal Infirmary, Edinburgh.
Dr. Baillie's research interest is the genetics of host susceptibility to severe infection. He led the GenISIS (Genetics of Influenza Susceptibility in Scotland) study and the host genetics component of the MOSAIC (Mechanisms of Severe Influenza Consortium) study. In his role as working group chair for genomics, pathogenesis and pharmacology for the International Severe Acute Respiratory Infection Consortium (ISARIC), he led the development of an integrated biological sampling protocol for use in outbreaks, which is supported by the World Health Organisation and has been adopted in many countries throughout the world.
Dr. Baillie's research is focused on using genomics and transcriptomics to better understand and treat critical illness. The fundamental problem is the lack of treatments to stop people dying from severe infections - a syndrome known as sepsis. We believe that a functional genomics approach can lead us to biological processes that might be amenable to treatment. Much of his work focuses on specific infections, such as influenza. He leads the GenOMICC (Genetics of Mortality in Critical Care) Study.
Dr. Ballie is currently highly involved in COVID-19 research.
To find out more, visit: www.baillielab.net
A review of the evidence